US Patent 8394607 Anti-CD22 antibodies and immunoconjugates and methods of use
Patent 8394607 was granted and assigned to Genentech on March, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8394607 Anti-CD22 antibodies and immunoconjugates and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
